Thank you for attending HCV-Flavi 2026!
The 32nd International Symposium on Hepatitis C Virus, Flaviviruses and Related Viruses was held in Scandinavia for the first time and with more than 430 participants, 150 poster presentations and over 140 oral presentations it is safe to say the symposium was a great success. The scientific program covered research in the fields of hepatitis C virus, orthoflaviviruses and related viruses, such as pesti-, pegi-, and other hepatitis viruses.
We hope you had a good time in Copenhagen and had the opportunity to connect with leading experts, researchers, and healthcare professionals from around the world to discuss the latest advancements.
Welcome to HCV-Flavi 2026
We warmly invite you to join the 32nd International Symposium on Hepatitis C Virus, Flaviviruses and Related Viruses (HCV-Flavi 2026) in Copenhagen, Denmark, from September 14-17, 2026! This esteemed meeting brings together leading minds and research in the fields of hepatitis C virus (HCV), orthoflaviviruses and related viruses. For its 32nd edition, we stand on the shoulders of giants who, since the discovery of HCV, have built the extraordinary research profile of this meeting, and of those who have more recently made it an equally important cornerstone in orthoflavivirus research. With the Copenhagen meeting, we will continue this legacy by highlighting the most pronounced advances in the field. At the same time, we are also dedicated to the important research on related viruses, such as pesti-, pegi-, and other hepatitis viruses.
Since its inception in 1992 this yearly meeting has rotated through venues in Europe, North America and Asia/Australia. In 2026, we are excited to bring it to Scandinavia for the first time. This symposium has a strong tradition of driving discoveries in virus replication, immune responses, pathogenesis and genetics, and providing the knowledge base for spectacular advances in antiviral and vaccine development. While HCV, orthoflaviviruses, and related viruses share many characteristics, their differences also allow for unique approaches that can cross-fertilize discoveries between them.
This event is your opportunity to connect with leading experts, researchers, and healthcare professionals from around the world to discuss the latest advancements. Our program will feature internationally renowned plenary speakers, oral presentations, pitch talks, and poster sessions in addition to social networking events.
Invited Speakers
Justin Bailey
Professor, Johns Hopkins University School of Medicine, US
Martin Beer
Professor Friedrich-Loeffler-Institut, DE
Leen Delang
Associate Professor, KU Leuven, BE
Heidi Drummer
Professor, Burnet Institute, AU
Anna Durbin
Professor, Johns Hopkins Bloomberg School of Public Health, US
Shirit Einav
Professor, Stanford University, US
Dahai Luo
Associate Professor, Nanyang Technological University, SG
Johan Neyts
Professor, University of Leuven, BE
Anna Överby Wernstedt
Professor, Umeå University, SE
Søren Riis Paludan
Professor, Aarhus University, DK
Selena Sagan
Professor, University of British Columbia Vancouver, CA
Meghan Vermillion
Gilead, US
Rogier Sanders
Professor, Amsterdam UMC, NL
Anna Överby Wernstedt
Professor, Umeå University, SE
Anna Överby Wernstedt
Professor, Umeå University, SE
Discussion session: Controlled Human Infection Model for vaccine development
- Jordan Feld, University of Toronto, CA
- Jake Liang, NIDDK, NIH, US
- Eleanor Barnes, University of Oxford, UK
Confirmed Session Chairs
- Eva Billerbeck, Albert Einstein College of Medicine, US
- Rowena Bull, University of New South Wales, AU
- Lars Anders Carlsson, Umeå University, SE
- Andrea Cox, Johns Hopkins Medicine, US
- Qiang Ding, Tsinghua University, CN
- Thomas Fuerst, University of Maryland, MD, US
- Branka Grubor, University of Adelaide, AU
- Eva Harris, University of California, Berkeley, CA, US
- Kenn Holmbeck, University of Copenhagen, DK
- Stacy Horner, Duke University School of Medicine, NC, US
- Amit Kapoor, Nationwide Children’s Hospital, OH, US
- Richard Kuhn, Purdue University, IN, US
- Mansun Law, Scripps Research, CA, US
- Volker Lohmann, University of Heidelberg, DE
- Mauricio Nogueira, Faculty of Medicine of São José do Rio Preto, BR
- Jean-Michel Pawlotsky, Hôpital Henri Mondor, Université Paris-Est, FR
- Ted Pierson, National Institutes of Health, MD, US
- Thomas Pietschmann, Twincore, DE
- Holly Ramage, Thomas Jefferson University, US
- Felix Rey, Institut Pasteur, FR
- Sara Gredmark Russ, Karolinska Institute, SE
- Daniel Růžek, Masaryk University, CZ
- Ashley St. John, Duke-NUS Medical School, SG
- Karin Stiasny, Medical University of Vienna, AT
- Jeppe Vinther, University of Copenhagen, DK
- Takashi Wakita, National Institute of Health Sciences, JP
- Nina Weis, Hvidovre Hospital, DK
Symposium Organizers
Jens Bukh, Judith M. Gottwein & Troels K. H. Scheel
Copenhagen Hepatitis C Program (CO-HEP), University of Copenhagen, Copenhagen University Hospital, Hvidovre